Related Experiment Videos
Reverse genetics system for the avian coronavirus infectious bronchitis virus
R Casais1, V Thiel, S G Siddell
1Division of Molecular Biology, Institute for Animal Health, Compton Laboratory, Compton, Newbury, Berkshire RG20 7NN, United Kingdom.
Journal of Virology
|November 17, 2001
Summary
Researchers developed a reverse-genetics system for avian coronavirus infectious bronchitis virus (IBV). This system enables the generation of genetically modified IBV, paving the way for precisely engineered vaccines against this poultry pathogen.
Area of Science:
- Virology
- Molecular Biology
- Genetics
Background:
- Advances in RNA virus molecular biology rely on generating infectious RNA from cDNA.
- Coronaviruses, including infectious bronchitis virus (IBV), pose challenges due to large genomes and cDNA instability, hindering reverse-genetics system development.
Purpose of the Study:
- To establish a functional reverse-genetics system for avian coronavirus infectious bronchitis virus (IBV).
- To enable the generation of recombinant IBV with specific genetic modifications.
Main Methods:
- Assembled full-length cDNA of the IBV genome downstream of a T7 RNA polymerase promoter.
- Cloned the IBV cDNA into the vaccinia virus genome.
- Generated infectious IBV RNA in situ via transfection into chick kidney cells infected with a T7 RNA polymerase-expressing fowlpox virus.
Main Results:
- Successfully generated infectious IBV RNA from the assembled cDNA.
- Recovered recombinant IBV containing two marker mutations.
- Demonstrated the feasibility of the reverse-genetics system for IBV.
Conclusions:
- Established a novel reverse-genetics system for infectious bronchitis virus (IBV).
- This system provides a platform for studying IBV molecular biology.
- This work establishes a paradigm for creating genetically defined IBV vaccines.